Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Cash from Financing Activities (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Cash from Financing Activities for 3 consecutive years, with $11.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities fell 1.07% year-over-year to $11.6 million, compared with a TTM value of $29.9 million through Sep 2025, up 160.56%, and an annual FY2024 reading of $23.0 million, up 274.31% over the prior year.
  • Cash from Financing Activities was $11.6 million for Q3 2025 at SBC Medical Group Holdings, up from $7.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $105.3 million in Q3 2023 and bottomed at -$280380.0 in Q1 2025.
  • Average Cash from Financing Activities over 3 years is $16.3 million, with a median of $7.2 million recorded in 2025.
  • Peak annual rise in Cash from Financing Activities hit 10491.67% in 2025, while the deepest fall reached 596.99% in 2025.
  • Year by year, Cash from Financing Activities stood at -$127221.0 in 2023, then surged by 9046.13% to $11.4 million in 2024, then grew by 1.64% to $11.6 million in 2025.
  • Business Quant data shows Cash from Financing Activities for SBC at $11.6 million in Q3 2025, $7.2 million in Q2 2025, and -$280380.0 in Q1 2025.